Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 13 studies | 46% ± 16% | |
GABAergic neuron | 5 studies | 31% ± 9% | |
interneuron | 4 studies | 23% ± 3% | |
neuron | 3 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 3154.77 | 2634 / 2642 | 97% | 154.35 | 682 / 705 |
prostate | 83% | 1239.09 | 204 / 245 | 68% | 25.78 | 339 / 502 |
breast | 52% | 740.65 | 238 / 459 | 81% | 85.36 | 900 / 1118 |
lung | 89% | 779.95 | 514 / 578 | 27% | 8.81 | 313 / 1155 |
ovary | 1% | 2.78 | 1 / 180 | 75% | 34.04 | 322 / 430 |
adrenal gland | 5% | 19.93 | 14 / 258 | 53% | 26.92 | 121 / 230 |
stomach | 32% | 99.96 | 116 / 359 | 14% | 3.51 | 39 / 286 |
uterus | 8% | 46.21 | 14 / 170 | 37% | 11.94 | 168 / 459 |
pancreas | 1% | 2.10 | 3 / 328 | 37% | 11.67 | 66 / 178 |
esophagus | 16% | 86.27 | 234 / 1445 | 18% | 4.12 | 33 / 183 |
bladder | 5% | 9.71 | 1 / 21 | 23% | 7.79 | 118 / 504 |
intestine | 5% | 26.52 | 53 / 966 | 13% | 3.23 | 71 / 527 |
thymus | 1% | 3.36 | 7 / 653 | 16% | 3.02 | 97 / 605 |
tonsil | 0% | 0 | 0 / 0 | 13% | 2.40 | 6 / 45 |
liver | 0% | 0 | 0 / 226 | 11% | 4.46 | 44 / 406 |
skin | 4% | 11.13 | 71 / 1809 | 4% | 1.20 | 17 / 472 |
adipose | 5% | 14.04 | 60 / 1204 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.31 | 10 / 901 |
heart | 1% | 2.88 | 6 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.61 | 2 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.19 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0098970 | Biological process | postsynaptic neurotransmitter receptor diffusion trapping |
GO_0042220 | Biological process | response to cocaine |
GO_0099590 | Biological process | neurotransmitter receptor internalization |
GO_2000311 | Biological process | regulation of AMPA receptor activity |
GO_0098943 | Biological process | neurotransmitter receptor transport, postsynaptic endosome to lysosome |
GO_0051968 | Biological process | positive regulation of synaptic transmission, glutamatergic |
GO_0019226 | Biological process | transmission of nerve impulse |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_1990454 | Cellular component | L-type voltage-gated calcium channel complex |
GO_0036477 | Cellular component | somatodendritic compartment |
GO_0030666 | Cellular component | endocytic vesicle membrane |
GO_0032281 | Cellular component | AMPA glutamate receptor complex |
GO_0009986 | Cellular component | cell surface |
GO_0044297 | Cellular component | cell body |
GO_0005246 | Molecular function | calcium channel regulator activity |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
GO_0016247 | Molecular function | channel regulator activity |
GO_0035255 | Molecular function | ionotropic glutamate receptor binding |
Gene name | CACNG4 |
Protein name | Voltage-dependent calcium channel gamma-4 subunit (Neuronal voltage-gated calcium channel gamma-4 subunit) (Transmembrane AMPAR regulatory protein gamma-4) (TARP gamma-4) |
Synonyms | |
Description | FUNCTION: Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit . Regulates the trafficking and gating properties of AMPA-selective glutamate receptors (AMPARs), including GRIA1 and GRIA4. Promotes their targeting to the cell membrane and synapses and modulates their gating properties by slowing their rates of activation, deactivation and desensitization and by mediating their resensitization . . |
Accessions | ENST00000262138.4 Q9UBN1 |